NCB traces Kashmir drug supply to Delhi, seizes huge cache of pharmaceutical preparations | File Image 
Jammu & Kashmir

NCB busts Delhi-Kashmir drug network, seizes over five lakh pharmaceutical preparations

Over five lakh tablets, capsules and bottles seized as NCB cracks Delhi-Kashmir drug racket

The Narcotics Control Bureau (NCB) has dismantled an alleged inter-state pharmaceutical drug trafficking network operating between Delhi and the Kashmir Valley, arresting four people and recovering more than half a million tablets, capsules and bottles of cough syrup from a clandestine godown in Shahdara, northeast Delhi.

The operation, conducted by the NCB’s Jammu Zonal Unit in coordination with its Delhi Zonal Unit, is part of the Centre’s drive to eliminate drug trafficking networks by December 31, 2029.

Bus interception leads to Delhi storage facility

The investigation began in the early hours of November 16, when NCB personnel intercepted a Srinagar-bound passenger bus near Mada Toll Plaza in Chenani, Udhampur district.

Around 7 kg of codeine-based cough syrup (CBCS) was allegedly recovered from a passenger, who is said to be a resident of Bhaderwah in Doda district.

The seizure prompted investigators to trace the suspected supply chain across the Kashmir Valley and Delhi. The agency subsequently arrested the alleged recipient, a resident of Anantnag, along with people suspected of being involved in the supply operation in the national capital.

Over five lakh tablets, capsules and bottles seized

Follow-up searches in Delhi on November 18 led to the recovery of 356 bottles of codeine-based cough syrup, officials said.

Investigators then identified a suspected clandestine storage facility operating from rented premises in Shahdara. Searches conducted on November 18 and 19 yielded more than five lakh tablets, capsules and bottles of pharmaceutical preparations containing tramadol hydrochloride, alprazolam, nitrazepam and codeine.

The NCB is now examining how the medicines were diverted from legitimate pharmaceutical channels into illicit circulation.

Probe focuses on suppliers and financial links

Officials said the investigation is aimed at establishing the source of the codeine-based cough syrup and determining where it was diverted from the lawful pharmaceutical supply chain.

The agency is pursuing leads to identify upstream suppliers and downstream distributors, while also tracing the financial links and arrangements that allegedly sustained the network.

The probe seeks to establish the wider structure of the operation and disrupt the channels through which pharmaceutical preparations were moved into illegal circulation.

Operation under Centre’s network-centric drug control strategy

The crackdown forms part of the NCB’s network-centric enforcement approach under the Vision Document on Narcotics Control 2026-2029. The strategy places emphasis on tracing consignments to their source and dismantling entire trafficking networks, rather than limiting action to seizures and arrests.

The Centre’s three-year roadmap, launched in June 2026, aims to make India drug-free by 2029 through intelligence-led enforcement, coordinated action and efforts to target the financial and logistical infrastructure of drug trafficking.

The NCB has urged citizens to share credible information about drug trafficking and the diversion of pharmaceutical substances through the national narcotics helpline, MANAS, on 1933.